{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T14:45:26Z","timestamp":1775054726140,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-026-04579-7","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T12:44:17Z","timestamp":1775047457000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differential diagnosis of familial dysalbuminemic hyperthyroxinemia , RTH, and TSHomas: A single-center retrospective analysis"],"prefix":"10.1007","volume":"91","author":[{"given":"Yuanmeng","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinqi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Chi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2261-7349","authenticated-orcid":false,"given":"Naishi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolan","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"issue":"1","key":"4579_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4158\/EP.1.1.4","volume":"1","author":"AE Heufelder","year":"1995","unstructured":"A.E. Heufelder, G.G. Klee, A.G. Wynne, H. Gharib, Familial dysalbuminemic hyperthyroxinemia: cumulative experience in 29 consecutive patients. Endocr. Pract. 1(1), 4\u20138 (1995)","journal-title":"Endocr. Pract."},{"issue":"5","key":"4579_CR2","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1373\/clinchem.2008.120303","volume":"55","author":"D Cartwright","year":"2009","unstructured":"D. Cartwright, P. O\u2019Shea, O. Rajanayagam, M. Agostini, P. Barker, C. Moran et al., Familial dysalbuminemic hyperthyroxinemia: a persistent diagnostic challenge. Clin. Chem. 55(5), 1044\u20131046 (2009)","journal-title":"Clin. Chem."},{"issue":"2","key":"4579_CR3","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1006\/bbrc.1994.1998","volume":"202","author":"T Sunthornthepvarakul","year":"1994","unstructured":"T. Sunthornthepvarakul, P. Angkeow, R.E. Weiss, Y. Hayashi, S. Refetoff, An identical missense mutation in the albumin gene results in Familial dysalbuminemic hyperthyroxinemia in 8 unrelated families. Biochem. Biophys. Res. Commun. 202(2), 781\u2013787 (1994)","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"4579_CR4","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1136\/jmg.31.5.355","volume":"31","author":"CE Petersen","year":"1994","unstructured":"C.E. Petersen, A.G. Scottolini, L.R. Cody, M. Mandel, N. Reimer, N.V. Bhagavan, A point mutation in the human serum albumin gene results in Familial dysalbuminaemic hyperthyroxinaemia. J. Med. Genet. 31(5), 355\u2013359 (1994)","journal-title":"J. Med. Genet."},{"key":"4579_CR5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3389\/fendo.2017.00297","volume":"8","author":"U Kragh-Hansen","year":"2017","unstructured":"U. Kragh-Hansen, M. Galliano, L. Minchiotti, Clinical, Genetic, and protein structural aspects of Familial dysalbuminemic hyperthyroxinemia and hypertriiodothyroninemia. Front. Endocrinol. (Lausanne). 8, 297 (2017)","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"4579_CR6","doi-asserted-by":"crossref","unstructured":"P. Beck-Peccoz, A. Lania, A. Beckers, K. Chatterjee, J.L. Wemeau, 2013 European thyroid association guidelines for the diagnosis and treatment of thyrotropin-secreting pituitary tumors. Eur Thyroid J. 2013;2(2):76\u201382","DOI":"10.1159\/000351007"},{"issue":"5","key":"4579_CR7","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1210\/er.2018-00119","volume":"39","author":"J Favresse","year":"2018","unstructured":"J. Favresse, M.C. Burlacu, D. Maiter, D. Gruson, Interferences with thyroid function immunoassays: clinical implications and detection algorithm. Endocr. Rev. 39(5), 830\u2013850 (2018)","journal-title":"Endocr. Rev."},{"key":"4579_CR8","doi-asserted-by":"publisher","first-page":"1102777","DOI":"10.3389\/fendo.2023.1102777","volume":"14","author":"L Zhao","year":"2023","unstructured":"L. Zhao, Y. Zhou, F. Huang, X. He, G. Mei, S. Wang et al., Clinical characteristics of Familial dysalbuminemic hyperthyroxinemia in Chinese patients and comparison of free thyroxine in three immunoassay methods. Front. Endocrinol. (Lausanne). 14, 1102777 (2023)","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"4579_CR9","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12902-023-01481-5","volume":"23","author":"Y Li","year":"2023","unstructured":"Y. Li, Y. Chi, X. Chai, H. Liu, N. Li, X. Lian, Familial dysalbuminemic hyperthyroxinemia combined with graves\u2019 disease: a rare case report. BMC Endocr. Disord. 23(1), 226 (2023)","journal-title":"BMC Endocr. Disord"},{"issue":"9","key":"4579_CR10","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1089\/thy.2019.0470","volume":"30","author":"R Han","year":"2020","unstructured":"R. Han, L. Shen, J. Zhang, J. Xie, W. Fang, Q. Sun et al., Diagnosing Thyrotropin-Secreting pituitary adenomas by Short-Term somatostatin analogue test. Thyroid. 30(9), 1236\u20131244 (2020)","journal-title":"Thyroid"},{"issue":"5","key":"4579_CR11","doi-asserted-by":"publisher","first-page":"780","DOI":"10.7326\/0003-4819-107-5-780_2","volume":"107","author":"DR DeCosimo","year":"1987","unstructured":"D.R. DeCosimo, S.L. Fang, L.E. Braverman, Prevalence of Familial dysalbuminemic hyperthyroxinemia in Hispanics. Ann. Intern. Med. 107(5), 780\u2013781 (1987)","journal-title":"Ann. Intern. Med."},{"issue":"7","key":"4579_CR12","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1016\/j.bbagen.2012.08.005","volume":"1830","author":"AM Dumitrescu","year":"2013","unstructured":"A.M. Dumitrescu, S. Refetoff, The syndromes of reduced sensitivity to thyroid hormone. Biochim. Biophys. Acta. 1830(7), 3987\u20134003 (2013)","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"4579_CR13","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s12020-016-0863-3","volume":"52","author":"FG Amlashi","year":"2016","unstructured":"F.G. Amlashi, N.A. Tritos, Thyrotropin-secreting pituitary adenomas: epidemiology, diagnosis, and management. Endocrine. 52(3), 427\u2013440 (2016)","journal-title":"Endocrine"},{"issue":"8","key":"4579_CR14","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1093\/clinchem\/47.8.1353","volume":"47","author":"JE Midgley","year":"2001","unstructured":"J.E. Midgley, Direct and indirect free thyroxine assay methods: theory and practice. Clin. Chem. 47(8), 1353\u20131363 (2001)","journal-title":"Clin. Chem."},{"issue":"1","key":"4579_CR15","first-page":"40","volume":"22","author":"WX Dai","year":"2005","unstructured":"W.X. Dai, Z.Y. Liu, Z.S. Guo, Z.X. Liu, Y.L. Dou, [A family with Familial dysalbuminaemic hyperthyroxinaemia]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 22(1), 40\u201343 (2005)","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi"},{"issue":"4","key":"4579_CR16","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1530\/eje.0.1410374","volume":"141","author":"KT Tang","year":"1999","unstructured":"K.T. Tang, H.J. Yang, K.B. Choo, H.D. Lin, S.L. Fang, L.E. Braverman, A point mutation in the albumin gene in a Chinese patient with Familial dysalbuminemic hyperthyroxinemia. Eur. J. Endocrinol. 141(4), 374\u2013378 (1999)","journal-title":"Eur. J. Endocrinol."},{"key":"4579_CR17","doi-asserted-by":"publisher","first-page":"5947415","DOI":"10.1155\/2019\/5947415","volume":"2019","author":"H Liu","year":"2019","unstructured":"H. Liu, J. Ran, C. Chen, G. Chen, P. Zhu, R. Tan et al., A Chinese family with Familial dysalbuminemic hyperthyroxinemia (FDH) due to R242H mutation on human albumin gene: reevaluating the role of FDH in patients with asymptomatic hyperthyroxinemia. Int. J. Endocrinol. 2019, 5947415 (2019)","journal-title":"Int. J. Endocrinol."},{"issue":"2","key":"4579_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0002-9343(87)90059-3","volume":"82","author":"RA Young","year":"1987","unstructured":"R.A. Young, S.S. Stoffer, L.E. Braverman, Familial dysalbuminemic hyperthyroxinemia associated with primary thyroid disease. Am. J. Med. 82(2), 221\u2013223 (1987)","journal-title":"Am. J. Med."},{"issue":"6567","key":"4579_CR19","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1136\/bmj.294.6567.286","volume":"294","author":"A Jones","year":"1987","unstructured":"A. Jones, M.R. Hopton, K.J. Gurling, J.S. Harrop, Iatrogenic hypothyroidism and postpartum hyperthyroidism in Familial dysalbuminaemic hyperthyroxinaemia. Br. Med. J. (Clin Res. Ed). 294(6567), 286 (1987)","journal-title":"Br. Med. J. (Clin Res. Ed)"},{"key":"4579_CR20","doi-asserted-by":"crossref","unstructured":"S. Khoo, G. Lyons, A. Solomon, S. Oddy, D. Halsall, K. Chatterjee et al., Familial dysalbuminemic hyperthyroxinemia confounding management of coexistent autoimmune thyroid disease. Endocrinol Diabetes Metab Case Rep. 2020;2020","DOI":"10.1530\/EDM-19-0161"},{"issue":"7","key":"4579_CR21","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.3390\/jcm9072105","volume":"9","author":"X. de Dieu","year":"2020","unstructured":"X. Dieu, N. Bouzamondo, C. Briet, F. Illouz, V. Moal, F. de Boux et al., Casson Familial dysalbuminemic hyperthyroxinemia: an underdiagnosed entity. J. Clin. Med. 9(7), 2105 (2020)","journal-title":"J. Clin. Med."},{"issue":"1","key":"4579_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/0004563220969150","volume":"58","author":"DJ Halsall","year":"2021","unstructured":"D.J. Halsall, S. Oddy, Clinical and laboratory aspects of 3,3\u2019,5\u2019-triiodothyronine (reverse T3). Ann. Clin. Biochem. 58(1), 29\u201337 (2021)","journal-title":"Ann. Clin. Biochem."},{"issue":"9","key":"4579_CR23","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/S2213-8587(19)30155-X","volume":"7","author":"S Groeneweg","year":"2019","unstructured":"S. Groeneweg, R.P. Peeters, C. Moran, A. Stoupa, F. Auriol, D. Tonduti et al., Effectiveness and safety of the tri-iodothyronine analogue triac in children and adults with MCT8 deficiency: an international, single-arm, open-label, phase 2 trial. Lancet Diabetes Endocrinol. 7(9), 695\u2013706 (2019)","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"4","key":"4579_CR24","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1210\/me.2010-0213","volume":"25","author":"O Barca-Mayo","year":"2011","unstructured":"O. Barca-Mayo, X.H. Liao, M. Alonso, Di C. Cosmo, A. Hernandez, S. Refetoff et al., Thyroid hormone receptor \u03b1 and regulation of type 3 deiodinase. Mol. Endocrinol. 25(4), 575\u2013583 (2011)","journal-title":"Mol. Endocrinol."},{"issue":"2","key":"4579_CR25","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3803\/EnM.2023.1877","volume":"39","author":"J Heo","year":"2024","unstructured":"J. Heo, Y.L. Suh, S.H. Kim, D.S. Kong, D.H. Nam, W.J. Lee et al., Clinical Characteristics, Diagnosis, and treatment of thyroid stimulating Hormone-Secreting pituitary neuroendocrine tumor (TSH PitNET): A Single-Center experience. Endocrinol. Metab. (Seoul). 39(2), 387\u2013396 (2024)","journal-title":"Endocrinol. Metab. (Seoul)"},{"issue":"2","key":"4579_CR26","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/j.1365-2265.2004.02192.x","volume":"62","author":"D Mannavola","year":"2005","unstructured":"D. Mannavola, L. Persani, G. Vannucchi, M. Zanardelli, L. Fugazzola, U. Verga et al., Different responses to chronic somatostatin analogues in patients with central hyperthyroidism. Clin. Endocrinol. (Oxf). 62(2), 176\u2013181 (2005)","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"12","key":"4579_CR27","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/s40618-019-01066-x","volume":"42","author":"P Beck-Peccoz","year":"2019","unstructured":"P. Beck-Peccoz, C. Giavoli, A. Lania, A 2019 update on TSH-secreting pituitary adenomas. J. Endocrinol. Invest. 42(12), 1401\u20131406 (2019)","journal-title":"J. Endocrinol. Invest."},{"issue":"3","key":"4579_CR28","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/cen.14921","volume":"99","author":"J Liu","year":"2023","unstructured":"J. Liu, Y. Yang, L. Duan, X. Chai, H. Zhu, K. Deng et al., Characteristics and response cutoff of octreotide suppression test in thyrotrophin (TSH)-secreting pituitary adenomas. Clin. Endocrinol. (Oxf). 99(3), 306\u2013314 (2023)","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"1","key":"4579_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1507\/endocrj.EJ14-0118","volume":"62","author":"N Fukuhara","year":"2015","unstructured":"N. Fukuhara, K. Horiguchi, H. Nishioka, H. Suzuki, A. Takeshita, Y. Takeuchi et al., Short-term preoperative octreotide treatment for TSH-secreting pituitary adenoma. Endocr. J. 62(1), 21\u201327 (2015)","journal-title":"Endocr. J."},{"issue":"1","key":"4579_CR30","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1507\/endocrj.K06-133","volume":"54","author":"A Yoshihara","year":"2007","unstructured":"A. Yoshihara, O. Isozaki, N. Hizuka, Y. Nozoe, C. Harada, M. Ono et al., Expression of type 5 somatostatin receptor in TSH-secreting pituitary adenomas: a possible marker for predicting long-term response to octreotide therapy. Endocr. J. 54(1), 133\u2013138 (2007)","journal-title":"Endocr. J."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04579-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-026-04579-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04579-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T12:44:19Z","timestamp":1775047459000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-026-04579-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4579"],"URL":"https:\/\/doi.org\/10.1007\/s12020-026-04579-7","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"21 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Peking Union Medical College Hospital, and informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"119"}}